• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Metastatic malignant disease of unknown primary origin

Diagnosis and management of metastatic malignant disease of unknown primary origin

Status:	History
Publication date:	July 2010
Wave:	14
Process:	CG
Topic area: Cancer Diagnostic procedures

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Fergus Macbeth
Communications manager:	Laura Gibson
Guidelines commissioning manager:	Claire Turner
Guidelines coordinator:	Anthony Gildea
Patient involvement lead:	Barbara Meredith
Implementation lead:	Stardom Furamera
Lead collaborating centre:	National Collaborating Centre for Cancer
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	15 February 2008
Consultation on draft scope with stakeholders:	21 January - 18 February 2008
Consultation on draft guideline with stakeholders:	02 December 2009 – 01 February 2010
Pre-publication check:	18 May 2010 - 01 January 2100
Publication date:	July 2010

Top

 

Project history

Date Update 15 May 2008 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process. 18 May 2010 The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

Top

 

Key documents

Metastatic malignant disease of unknown primary origin: remit 14 August 2008 Metastatic malignant disease of unknown primary origin: stakeholder lists and how to register 09 June 2010 Metastatic malignant disease of unknown primary origin: scoping workshop, consultation and final scope 22 July 2008 Metastatic malignant disease of unknown primary origin: guideline development and consultation 02 December 2009 Metastatic malignant disease of unknown primary origin: pre-publication check 17 May 2010 National Collaborating Centre for Cancer 02 June 2003 The guideline development process - an overview for stakeholders, the public and the NHS 16 June 2009

This page was last updated: 16 August 2011